Multifactorial etiology of gastric cancer

Methods in Molecular Biology

Volumn 863, Issue , 2012, Pages 411-435

  Zabaleta, Jovanny ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gastric cancer; Helicobacter pylori; Methylation; Single nucleotide polymorphisms

Indexed keywords

CYTOKINE; TUMOR MARKER;

DNA METHYLATION; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PREVALENCE; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH MUCOSA; STOMACH TUMOR; T LYMPHOCYTE;

CYTOKINES; DNA METHYLATION; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS; STOMACH NEOPLASMS; T-LYMPHOCYTES; TUMOR MARKERS, BIOLOGICAL;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 84859940334     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-612-8_26     Document Type: Review

References (218)

1. GLOBOCAN. Stomach Cancer Incidence and Mortality Worldwide in 2008. http://globocan.iarc.fr/ . 2008.
2. Parkin, D.M., Bray, F., Ferlay, J., and Pisani, P. (2005) Global cancer statistics, 2002. CA Cancer J. Clin. , 55, 74-108.
3. Parkin, D.M. (2004) International variation. Oncogene , 23, 6329-6340. (Pubitemid 39272833)
4. Jemal, A., Siegel, R., Xu, J., and Ward, E. (2010) Cancer statistics, 2010. CA Cancer J. Clin. , 60, 277-300.
5. Jass, J.R., Sobin, L.H., and Watanabe, H. (1990) The World Health Organization's histologic classifi cation of gastrointestinal tumors. A commentary on the second edition. Cancer , 66, 2162-2167.
6. Mulligan, R.M. (1972) Histogenesis and biologic behavior of gastric carcinoma. Pathol. Annu. , 7, 349-415.
7. Ming, S.C. (1977) Gastric carcinoma. A pathobiological classifi cation. Cancer , 39, 2475-2485. (Pubitemid 8144816)
8. Laurén, P. (1965) The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-Type carcinoma. An attempt at histo-clinical classifi cation. Acta Pathol. Microbiol. Scand. , 64, 31-49.
9. Goseki, N., Takizawa, T., and Koike, M. (1992) Differences in the mode of the extension of gastric cancer classifi ed by histological type: New histological classifi cation of gastric carcinoma. Gut , 33, 606-612.
10. Crew, K.D. and Neugut, A.I. (2006) Epidemiology of gastric cancer. World J Gastroenterol. , 12, 354-362. (Pubitemid 43329250)
11. Correa, P., Sasano, N., Stemmermann, G.N., and Haenszel, W. (1973) Pathology of gastric carcinoma in Japanese populations: Comparisons between Miyagi prefecture, Japan, and Hawaii. J Natl. Cancer Inst. , 51, 1449-1459.
12. Mohar, A., Suchil-Bernal, L., Hernandez-Guerrero, A., Podolsky-Rapoport, I., Herrera-Goepfert, R., Mora-Tiscareno, A. et al. (1997) Intestinal type: Diffuse type ratio of gastric carcinoma in a Mexican population. J Exp. Clin. Cancer Res. , 16, 189-194. (Pubitemid 27376579)
13. Kaneko, S. and Yoshimura, T. (2001) Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989. Br. J Cancer , 84, 400-405. (Pubitemid 32154436)
14. Henson, D.E., Dittus, C., Younes, M., Nguyen, H., and Bores-Saavedra, J. (2004) Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: Increase in the signet ring cell type. Arch. Pathol. Lab Med. , 128, 765-770. (Pubitemid 38856886)
15. IARC. IARC monograph on the evaluation of carcinogenic risks to humans:Schistosomes, liver fl ukes and Helicobacter pylori . IARC 61, 177-240. 1994.
16. Suerbaum, S. and Michetti, P. (2002) Helicobacter pylori infection. N. Engl. J Med. , 347, 1175-1186.
17. Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M. et al. (2001) Helicobacter pylori infection and the development of gastric cancer. N. Engl. J Med. , 345, 784-789.
18. Wroblewski, L.E., Peek, R.M., Jr., and Wilson, K.T. (2010) Helicobacter pylori and gastric cancer: Factors that modulate disease risk. Clin. Microbiol. Rev. , 23, 713-739.
19. Dixon, M.F., Genta, R.M., Yardley, J.H., and Correa, P. (1996) Classifi cation and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. , 20, 1161-1181.
20. Hansson, L.E., Nyren, O., Hsing, A.W., Bergstrom, R., Josefsson, S., Chow, W.H. et al. (1996) The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N. Engl. J Med. , 335, 242-249. (Pubitemid 26249572)
21. Correa, P. and Houghton, J. (2007) Carcinogenesis of Helicobacter pylori. Gastroenterology , 133, 659-672. (Pubitemid 47187360)
22. Zabaleta, J., Camargo, M.C., Piazuelo, M.B., Fontham, E., Schneider, B.G., Sicinschi, L.A. et al. (2006) Association of interleukin-1beta gene polymorphisms with precancerous gastric lesions in African Americans and Caucasians. Am. J. Gastroenterol. , 101, 163-171. (Pubitemid 43381725)
23. Rugge, M., Correa, P., Dixon, M.F., Hattori, T., Leandro, G., Lewin, K. et al. (2000) Gastric dysplasia: The Padova international classifi cation. Am. J Surg. Pathol. , 24, 167-176. (Pubitemid 30078704)
24. Correa, P., Haenszel, W., Cuello, C., Zavala, D., Fontham, E., Zarama, G. et al. (1990) Gastric precancerous process in a high risk population: Cohort follow-up. Cancer Res. , 50, 4737-4740. (Pubitemid 20230422)
25. Coussens, L.M. and Werb, Z. (2002) Infl ammation and cancer. Nature , 420, 860-867.
26. El-Omar, E.M., Carrington, M., Chow, W.H., McColl, K.E., Bream, J.H., Young, H.A. et al. (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature , 404, 398-402. (Pubitemid 30164342)
27. Alpizar-Alpizar,W., Perez-Perez, G.I., Une, C., Cuenca, P., and Sierra, R. (2005) Association of interleukin-1B and interleukin-1RN polymorphisms with gastric cancer in a high-risk population of Costa Rica. Clin. Exp. Med. , 5, 169-176. (Pubitemid 41813760)
28. Machado, J.C., Figueiredo, C., Canedo, P., Pharoah, P., Carvalho, R., Nabais, S. et al. (2003) A proinfl ammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology , 125, 364-371. (Pubitemid 36929416)
29. El-Omar, E.M., Rabkin, C.S., Gammon, M.D., Vaughan, T.L., Risch, H.A., Schoenberg, J.B. et al. (2003) Increased risk of noncardia gastric cancer associated with proinfl ammatory cytokine gene polymorphisms. Gastroenterology , 124, 1193-1201. (Pubitemid 36531795)
30. Zabaleta, J., Camargo, M.C., Ritchie, M.D., Piazuelo, M.B., Sierra, R.A., Turner, S.D. et al. (2011) Association of haplotypes of infl ammation-related genes with gastric preneoplastic lesions in African Americans and Caucasians. Int. J Cancer , 128, 668-675.
31. Banatvala, N., Mayo, K., Megraud, F., Jennings, R., Deeks, J.J., and Feldman, R.A. (1993) The cohort effect and Helicobacter pylori. J Infect. Dis. , 168, 219-221. (Pubitemid 23178754)
32. Lindkvist, P., Asrat, D., Nilsson, I., Tsega, E., Olsson, G.L., Wretlind, B. et al. (1996) Age at acquisition of Helicobacter pylori infection: Comparison of a high and a low prevalence country. Scand. J Infect. Dis. , 28, 181-184. (Pubitemid 26169491)
33. Fiedorek, S.C., Malaty, H.M., Evans, D.L., Pumphrey, C.L., Casteel, H.B., Evans, D.J., Jr. et al. (1991) Factors infl uencing the epidemiology of Helicobacter pylori infection in children. Pediatrics , 88, 578-582.
34. Sitas, F., Yarnell, J., and Forman, D. (1992) Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut , 33, 1582.
35. Cover, T.L. and Blaser, M.J. (1992) Purifi cation and characterization of the vacuolating toxin from Helicobacter pylori. J Biol. Chem. , 267, 10570-10575.
36. Ilver, D., Barone, S., Mercati, D., Lupetti, P., and Telford, J.L. (2004) Helicobacter pylori toxin VacA is transferred to host cells via a novel contact-dependent mechanism. Cell Microbiol. , 6, 167-174. (Pubitemid 38111597)
37. Leunk, R.D., Johnson, P.T., David, B.C., Kraft, W.G., and Morgan, D.R. (1988) Cytotoxic activity in broth-culture fi ltrates of Campylobacter pylori. J Med. Microbiol. , 26, 93-99.
38. Szabo, I., Brutsche, S., Tombola, F., Moschioni, M., Satin, B., Telford, J.L. et al. (1999) Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J , 18, 5517-5527. (Pubitemid 29486371)
39. Tombola, F., Morbiato, L., Del, G.G., Rappuoli, R., Zoratti, M., and Papini, E. (2001) The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia. J. Clin. Invest , 108, 929-937. (Pubitemid 32880301)
40. Mobley, H.L., Island, M.D., and Hausinger, R.P. (1995) Molecular biology of microbial ureases. Microbiol. Rev. , 59, 451-480.
41. Eaton, K.A., Brooks, C.L., Morgan, D.R., and Krakowka, S. (1991) Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect. Immun. , 59, 2470-2475.
42. Eaton, K.A. and Krakowka, S. (1994) Effect of gastric pH on urease-dependent colonization of gnotobiotic piglets by Helicobacter pylori. Infect. Immun. , 62, 3604-3607. (Pubitemid 24264297)
43. Bauerfeind, P., Garner, R., Dunn, B.E., and Mobley, H.L. (1997) Synthesis and activity of Helicobacter pylori urease and catalase at low pH. Gut , 40, 25-30. (Pubitemid 27079746)
44. Goodwin, C.S., Armstrong, J.A., and Marshall, B.J. (1986) Campylobacter pyloridis, gastritis, and peptic ulceration. J. Clin. Pathol. , 39, 353-365. (Pubitemid 16046763)
45. Smoot, D.T., Mobley, H.L., Chippendale, G.R., Lewison, J.F., and Resau, J.H. (1990) Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect. Immun. , 58, 1992-1994. (Pubitemid 20176403)
46. Odenbreit, S., Puls, J., Sedlmaier, B., Gerland, E., Fischer, W., and Haas, R. (2000) Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science , 287, 1497-1500. (Pubitemid 30127145)
47. Backert, S., Ziska, E., Brinkmann, V., Zimny-Arndt, U., Fauconnier, A., Jungblut, P.R. et al. (2000) Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol. , 2, 155-164. (Pubitemid 30368030)
48. Stein, M., Bagnoli, F., Halenbeck, R., Rappuoli, R., Fantl, W.J., and Covacci, A. (2002) c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol. Microbiol. , 43, 971-980. (Pubitemid 34415720)
49. Higashi, H., Tsutsumi, R., Muto, S., Sugiyama, T., Azuma, T., Asaka, M. et al. (2002) SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science , 295, 683-686. (Pubitemid 34111828)
50. Puls, J., Fischer, W., and Haas, R. (2002) Activation of Helicobacter pylori CagA by tyrosine phosphorylation is essential for dephosphorylation of host cell proteins in gastric epithelial cells. Mol. Microbiol. , 43, 961-969. (Pubitemid 34415719)
51. Loh, J.T., Torres, V.J., and Cover, T.L. (2007) Regulation of Helicobacter pylori cagA expression in response to salt. Cancer Res. , 67, 4709-4715. (Pubitemid 46910177)
52. Segal, E.D., Cha, J., Lo, J., Falkow, S., and Tompkins, L.S. (1999) Altered states: Involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl. Acad. Sci. U. S. A , 96, 14559-14564. (Pubitemid 30000689)
53. Kunkel, S.L., Standiford, T., Kasahara, K., and Strieter, R.M. (1991) Interleukin-8 (IL-8): The major neutrophil chemotactic factor in the lung. Exp. Lung Res. , 17, 17-23.
54. Papoff, P., Fiorucci, P., Ottaviano, C., and Bucci, G. (1995) Interleukin-8: A potent neutrophil chemotactic factor. Arch. Dis. Child Fetal Neonatal Ed , 73, F54.
55. Matsushima, K., Baldwin, E.T., and Mukaida, N. (1992) Interleukin-8 and MCAF: Novel leukocyte recruitment and activating cytokines. Chem. Immunol. , 51, 236-265.
56. Roebuck, K.A. (1999) Regulation of interleukin-8 gene expression. J. Interferon Cytokine Res. , 19, 429-438. (Pubitemid 29269932)
57. McGee, D.J., Radcliff, F.J., Mendz, G.L., Ferrero, R.L., and Mobley, H.L. (1999) Helicobacter pylori rocF is required for arginase activity and acid protection in vitro but is not essential for colonization of mice or for urease activity. J. Bacteriol. , 181, 7314-7322.
58. Tomb, J.F., White, O., Kerlavage, A.R., Clayton, R.A., Sutton, G.G., Fleischmann, R.D. et al. (1997) The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature , 388, 539-547. (Pubitemid 27339996)
59. Alm, R.A., Ling, L.S., Moir, D.T., King, B.L., Brown, E.D., Doig, P.C. et al. (1999) Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature , 397, 176-180.
60. Sekowska, A., Danchin, A., and Risler, J.L. (2000) Phylogeny of related functions: The case of polyamine biosynthetic enzymes. Microbiology , 146 (Pt 8), 1815-1828. (Pubitemid 30639258)
61. Tabor, C.W. and Tabor, H. (1984) Polyamines. Annu. Rev. Biochem. , 53, 749-790.
62. Roberts, S.C., Tancer, M.J., Polinsky, M.R., Gibson, K.M., Heby, O., and Ullman, B. (2004) Arginase plays a pivotal role in polyamine precursor metabolism in Leishmania. Characterization of gene deletion mutants. J. Biol. Chem. , 279, 23668-23678. (Pubitemid 38685683)
63. Mendz, G.L. and Hazell, S.L. (1995) Aminoacid utilization by Helicobacter pylori. Int. J. Biochem. Cell Biol. , 27, 1085-1093.
64. Zabaleta, J., McGee, D.J., Zea, A.H., Hernandez, C.P., Rodriguez, P.C., Sierra, R.A. et al. (2004) Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta). J. Immunol. , 173, 586-593. (Pubitemid 38797387)
65. Gobert, A.P., McGee, D.J., Akhtar, M., Mendz, G.L., Newton, J.C., Cheng, Y. et al. (2001) Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: A strategy for bacterial survival. Proc. Natl. Acad. Sci. U. S. A , 98, 13844-13849. (Pubitemid 33115986)
66. Chmiela, M., Lelwala-Guruge, J.A., Wadstrom, T., and Rudnicka, W. (1996) The stimulation and inhibition of T cell proliferation by Helicobacter pylori components. J. Physiol Pharmacol. , 47, 195-202. (Pubitemid 26124906)
67. Rudnicka, W., Covacci, A., Wadstrom, T., and Chmiela, M. (1998) A recombinant fragment of Helicobacter pylori CagA affects proliferation of human cells. J. Physiol Pharmacol. , 49, 111-119. (Pubitemid 28168396)
68. Meyer, F., Wilson, K.T., and James, S.P. (2000) Modulation of innate cytokine responses by products of Helicobacter pylori. Infect. Immun. , 68, 6265-6272.
69. Knipp, U., Birkholz, S., Kaup, W., and Opferkuch, W. (1996) Partial characterization of a cell proliferation-inhibiting protein produced by Helicobacter pylori. Infect. Immun. , 64, 3491-3496. (Pubitemid 26298665)
70. Paziak-Domanska, B., Chmiela, M., Jarosinska, A., and Rudnicka, W. (2000) Potential role of CagA in the inhibition of T cell reactivity in Helicobacter pylori infections. Cell Immunol. , 202, 136-139. (Pubitemid 30612720)
71. Ricci, V., Ciacci, C., Zarrilli, R., Sommi, P., Tummuru, M.K., Del Vecchio, B.C. et al. (1996) Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: Role of VacA and CagA. Infect. Immun. , 64, 2829-2833. (Pubitemid 26226856)
72. Smoot, D.T., Wynn, Z., Elliott, T.B., Allen, C.R., Mekasha, G., Naab, T. et al. (1999) Effects of Helicobacter pylori on proliferation of gastric epithelial cells in vitro. Am. J. Gastroenterol. , 94, 1508-1511. (Pubitemid 29263068)
73. Rokkas, T., Ladas, S., Liatsos, C., Petridou, E., Papatheodorou, G., Theocharis, S. et al. (1999) Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis. Dig. Dis. Sci. , 44, 487-493. (Pubitemid 29137956)
74. Kim, C.W., Choi, S.H., Chung, E.J., Lee, M.J., Byun, E.K., Ryu, M.H. et al. (1999) Alteration of signal-Transducing molecules and phenotypical characteristics in peripheral blood lymphocytes from gastric carcinoma patients. Pathobiology , 67, 123-128. (Pubitemid 29304372)
75. Takahashi, A., Kono, K., Amemiya, H., Iizuka, H., Fujii, H., and Matsumoto, Y. (2001) Elevated caspase-3 activity in peripheral blood T cells coexists with increased degree of T-cell apoptosis and down-regulation of TCR zeta molecules in patients with gastric cancer. Clin. Cancer Res. , 7, 74-80. (Pubitemid 32110207)
76. Ishigami, S., Natsugoe, S., Miyazono, F., Tokuda, K., Nakajo, A., Matsumoto, M. et al. (2004) CD3 zeta expression of regional lymph node and peripheral blood lymphocytes in gastric cancer. Anticancer Res. , 24, 2123-2126. (Pubitemid 38954645)
77. Roth, K.A., Kapadia, S.B., Martin, S.M., and Lorenz, R.G. (1999) Cellular immune responses are essential for the development of Helicobacter felis-Associated gastric pathology. J. Immunol. , 163, 1490-1497. (Pubitemid 29352771)
78. Mohammadi, M., Nedrud, J., Redline, R., Lycke, N., and Czinn, S.J. (1997) Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology , 113, 1848-1857. (Pubitemid 27512143)
79. Nedrud, J.G., Mohammadi, M., Blanchard, T., Redline, R., and Czinn, S.J. (1998) TH1/TH2 lymphocyte responses in Helicobacter infections. In Hunt,R. and Tycgat,S. (eds.) Helicobacter pylori. Mechanisms to clinical cure . Kluwer Academics Publishers, Boston, pp 101-9.
80. Bamford, K.B., Fan, X., Crowe, S.E., Leary, J.F., Gourley, W.K., Luthra, G.K. et al. (1998) Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology , 114, 482-492. (Pubitemid 28141193)
81. Lindholm, C., Quiding-Jarbrink, M., Lonroth, H., Hamlet, A., and Svennerholm, A.M. (1998) Local cytokine response in Helicobacter pylori-infected subjects. Infect. Immun. , 66, 5964-5971. (Pubitemid 28531859)
82. Yamaoka, Y., Kodama, T., Kita, M., Imanishi, J., Kashima, K., and Graham, D.Y. (2001) Relation between cytokines and Helicobacter pylori in gastric cancer. Helicobacter. , 6, 116-124. (Pubitemid 32601670)
83. Morris, S.M., Jr. (2004) Recent advances in arginine metabolism. Curr. Opin. Clin. Nutr. Metab Care , 7, 45-51. (Pubitemid 40348183)
84. Roth, E., Steininger, R., Winkler, S., Langle, F., Grunberger, T., Fugger, R. et al. (1994) L-Arginine defi ciency after liver transplantation as an effect of arginase effl ux from the graft. Infl uence on nitric oxide metabolism. Transplantation , 57, 665-669.
85. Zea, A.H., Rodriguez, P.C., Atkins, M.B., Hernandez, C., Signoretti, S., Zabaleta, J. et al. (2005) Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: A mechanism of tumor evasion. Cancer Res. , 65, 3044-3048. (Pubitemid 40524582)
86. Rodriguez, P.C., Quiceno, D.G., Zabaleta, J., Ortiz, B., Zea, A.H., Piazuelo, M.B. et al. (2004) Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. , 64, 5839-5849. (Pubitemid 39095585)
87. Rodriguez, P.C., Zea, A.H., Culotta, K.S., Zabaleta, J., Ochoa, J.B., and Ochoa, A.C. (2002) Regulation of T cell receptor CD3zeta chain expression by L-Arginine. J. Biol. Chem. , 277, 21123-21129. (Pubitemid 34952247)
88. Munder, M., Mollinedo, F., Calafat, J., Canchado, J., Gil-Lamaignere, C., Fuentes, J.M. et al. (2005) Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood , 105, 2549-2556. (Pubitemid 40387058)
89. Munder, M., Schneider, H., Luckner, C., Giese, T., Langhans, C.D., Fuentes, J.M. et al. (2006) Suppression of T-cell functions by human granulocyte arginase. Blood , 108, 1627-1634. (Pubitemid 44316131)
90. Kropf, P., Baud, D., Marshall, S.E., Munder, M., Mosley, A., Fuentes, J.M. et al. (2007) Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy. Eur. J. Immunol. , 37, 935-945. (Pubitemid 46925331)
91. Chang, C.I., Liao, J.C., and Kuo, L. (2001) Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res. , 61, 1100-1106. (Pubitemid 32174431)
92. Mendez, J.D. and Arreola, M.A. (1992) Effect of L-Arginine on pancreatic arginase activity and polyamines in alloxan treated rats. Biochem. Int. , 28, 569-575. (Pubitemid 23027074)
93. Mori, M. and Gotoh, T. (2000) Regulation of nitric oxide production by arginine metabolic enzymes. Biochem. Biophys. Res. Commun. , 275, 715-719.
94. Murray, H.W. and Teitelbaum, R.F. (1992) L-Arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J Infect. Dis. , 165, 513-517.
95. Das, P., Lahiri, A., Lahiri, A., and Chakravortty, D. (2010) Modulation of the arginase pathway in the context of microbial pathogenesis: A metabolic enzyme moonlighting as an immune modulator. PLoS. Pathog. , 6, e1000899.
96. Hung, C.Y., Xue, J., and Cole, G.T. (2007) Virulence mechanisms of coccidioides. Ann. N. Y. Acad. Sci. , 1111, 225-235. (Pubitemid 47573022)
97. Luiking, Y.C., Poeze, M., Dejong, C.H., Ramsay, G., and Deutz, N.E. (2004) Sepsis: An arginine defi ciency state? Crit Care Med. , 32, 2135-2145.
98. Luiking, Y.C., Poeze, M., Ramsay, G., and Deutz, N.E. (2005) The role of arginine in infection and sepsis. JPEN J Parenter. Enteral Nutr. , 29, S70-S74.
99. Molnar, B., Galamb, O., Sipos, F., Leiszter, K., and Tulassay, Z. (2010) Molecular pathogenesis of Helicobacter pylori infection: The role of bacterial virulence factors. Dig. Dis. , 28, 604-608.
100. Mori, M. and Gotoh, T. (2004) Arginine metabolic enzymes, nitric oxide and infection. J. Nutr. , 134, 2820S-2825S. (Pubitemid 39315229)
101. Wanasen, N. and Soong, L. (2008) L-Arginine metabolism and its impact on host immunity against Leishmania infection. Immunol. Res. , 41, 15-25. (Pubitemid 351903815)
102. Mendz, G.L., Holmes, E.M., and Ferrero, R.L. (1998) In situ characterization of Helicobacter pylori arginase. Biochim. Biophys. Acta , 1388, 465-477. (Pubitemid 28526608)
103. Lewis, N.D., Asim, M., Barry, D.P., Singh, K., de, S.T., Boucher, J.L. et al. (2010) Arginase II restricts host defense to Helicobacter pylori by attenuating inducible nitric oxide synthase translation in macrophages. J Immunol. , 184, 2572-2582.
104. Gobert, A.P., Cheng, Y., Wang, J.Y., Boucher, J.L., Iyer, R.K., Cederbaum, S.D. et al. (2002) Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J Immunol. , 168, 4692-4700. (Pubitemid 34441377)
105. Lewis, N.D., Asim, M., Barry, D.P., de, S.T., Singh, K., Piazuelo, M.B. et al. (2011) Immune Evasion by Helicobacter pylori Is Mediated by Induction of Macrophage Arginase II. J Immunol. , 186, 3632-3641.
106. Hoffman, S.M. and Fleming, S.D. (2010) Natural Helicobacter infection modulates mouse intestinal muscularis macrophage responses. Cell Biochem. Funct. , 28, 686-694.
107. el-Zimaity, H.M. and Graham, D.Y. (2001) Ultrastructural evidence of in vivo phagocytosis of Helicobacter pylori. Ultrastruct. Pathol. , 25, 159. (Pubitemid 32493529)
108. Zu, Y., Cassai, N.D., and Sidhu, G.S. (2000) Light microscopic and ultrastructural evidence of in vivo phagocytosis of Helicobacter pylori by neutrophils. Ultrastruct. Pathol. , 24, 319-323.
109. Ozbek, A., Ozbek, E., Dursun, H., Kalkan, Y., and Demirci, T. (2010) Can Helicobacter pylori invade human gastric mucosa?: An in vivo study using electron microscopy, immunohistochemical methods, and real-Time polymerase chain reaction. J. Clin. Gastroenterol. , 44, 416-422.
110. Ramarao, N., Gray-Owen, S.D., Backert, S., and Meyer, T.F. (2000) Helicobacter pylori inhibits phagocytosis by professional phagocytes involving type IV secretion components. Mol. Microbiol. , 37, 1389-1404.
111. Allen, L.A., Schlesinger, L.S., and Kang, B. (2000) Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. J Exp. Med. , 191, 115-128.
112. Zheng, P.Y. and Jones, N.L. (2003) Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein. Cell Microbiol. , 5, 25-40. (Pubitemid 36395118)
113. Ramarao, N. and Meyer, T.F. (2001) Helicobacter pylori resists phagocytosis by macrophages: quantitative assessment by confocal microscopy and fl uorescence-Activated cell sorting. Infect. Immun. , 69, 2604-2611. (Pubitemid 32239735)
114. Wang, Y.H., Wu, J.J., and Lei, H.Y. (2009) When Helicobacter pylori invades and replicates in the cells. Autophagy. , 5, 540-542.
115. Turner, D.M., Williams, D.M., Sankaran, D., Lazarus, M., Sinnott, P.J., and Hutchinson, I.V. (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet. , 24, 1-8. (Pubitemid 27050850)
116. Rad,R., Dossumbekova, A., Neu, B., Lang, R., Bauer, S., Saur, D. et al. (2004) Cytokine gene polymorphisms infl uence mucosal cytokine expression, gastric infl ammation, and host specific colonisation during Helicobacter pylori infection. Gut , 53, 1082-1089. (Pubitemid 38961959)
117. Hwang, I.R., Kodama, T., Kikuchi, S., Sakai, K., Peterson, L.E., Graham, D.Y. et al. (2002) Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology , 123, 1793-1803. (Pubitemid 35408303)
118. Pociot, F., Molvig, J., Wogensen, L., Worsaae, H., and Nerup, J. (1992) A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur. J. Clin. Invest , 22, 396-402.
119. Kroeger, K.M., Carville, K.S., and Abraham, L.J. (1997) The -308 tumor necrosis factoralpha promoter polymorphism effects transcription. Mol. Immunol. , 34, 391-399. (Pubitemid 27368335)
120. Wilson, A.G., Symons, J.A., McDowell, T.L., McDevitt, H.O., and Duff, G.W. (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. U. S. A , 94, 3195-3199. (Pubitemid 27157287)
121. Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J.S., Humphries, S. et al. (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest , 102, 1369-1376. (Pubitemid 28467565)
122. Terry, C.F., Loukaci, V., and Green, F.R. (2000) Cooperative infl uence of genetic polymorphisms on interleukin 6 transcriptional regulation. J. Biol. Chem. , 275, 18138-18144. (Pubitemid 30414764)
123. Abdallah, A.N., Cucchi-Mouillot, P., Biteau, N., Cassaigne, A., Haras, D., and Iron, A. (1999) Analysis of the polymorphism of the tumour necrosis factor (TNF) gene and promoter and of circulating TNF-Alpha levels in heart-Transplant patients suffering or not suffering from severe rejection. Eur. J. Immunogenet. , 26, 249-255. (Pubitemid 29364019)
124. Bunnapradist, S. and Jordan, S.C. (2000) The role of cytokines and cytokine gene polymorphism in T-cell activation and allograft rejection. Ann. Acad. Med. Singapore , 29, 412-416.
125. Hajeer, A.H., Lazarus, M., Turner, D., Mageed, R.A., Vencovsky, J., Sinnott, P. et al. (1998) IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand. J. Rheumatol. , 27, 142-145. (Pubitemid 28172572)
126. Cabrera, M., Shaw, M.A., Sharples, C., Williams, H., Castes, M., Convit, J. et al. (1995) Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J. Exp. Med. , 182, 1259-1264.
127. Wilkinson, R.J., Patel, P., Llewelyn, M., Hirsch, C.S., Pasvol, G., Snounou, G. et al. (1999) Infl uence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J. Exp. Med. , 189, 1863-1874.
128. SEER. SEER Cancer Statistics Review 1975-2004. http://seer.cancer.gov/ csr/1975-2004/results-merged/topic-inc-Trends.pdf . 2004.
129. Cancer Health Disparities. http://www.cancer. gov/cancertopics/types/ disparities . 2008.
130. Gabriel, S.B., Schaffner, S.F., Nguyen, H., Moore, J.M., Roy, J., Blumenstiel, B. et al. (2002) The structure of haplotype blocks in the human genome. Science , 296, 2225-2229. (Pubitemid 34680308)
131. Huang, W., He, Y., Wang, H., Wang, Y., Liu, Y., Wang, Y. et al. (2006) Linkage disequilibrium sharing and haplotype-Tagged SNP portability between populations. Proc Natl. Acad. Sci. U. S. A , 103, 1418-1421. (Pubitemid 43191180)
132. Epplein, M., Signorello, L.B., Zheng, W., Peek, R.M., Jr., Michel, A., Williams, S.M. et al. (2011) Race, African ancestry, and Helicobacter pylori infection in a low-income United States population. Cancer Epidemiol. Biomarkers Prev. .
133. Lee, C.G., Gottesman, M.M., Cardarelli, C.O., Ramachandra, M., Jeang, K.T., Ambudkar, S.V. et al. (1998) HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry , 37, 3594-3601. (Pubitemid 28162914)
134. Lee, C.G. and Gottesman, M.M. (1998) HIV-1 protease inhibitors and the MDR1 multidrug transporter. J. Clin. Invest , 101, 287-288. (Pubitemid 28067323)
135. Balram, C., Sharma, A., Sivathasan, C., and Lee, E.J. (2003) Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: Phenotypic-genotypic correlates. Br. J. Clin. Pharmacol. , 56, 78-83. (Pubitemid 36886491)
136. Hitzl, M., Drescher, S., van der, K.H., Schaffeler, E., Fischer, J., Schwab, M. et al. (2001) The C3435T mutation in the human MDR1 gene is associated with altered effl ux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics , 11, 293-298. (Pubitemid 32537402)
137. Hoffmeyer, S., Burk, O., von, R.O., Arnold, H.P., Brockmoller, J., Johne, A. et al. (2000) Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci. U. S. A , 97, 3473-3478. (Pubitemid 30183327)
138. Tanabe, M., Ieiri, I., Nagata, N., Inoue, K., Ito, S., Kanamori, Y. et al. (2001) Expression of P-glycoprotein in human placenta: Relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J. Pharmacol. Exp. Ther. , 297, 1137-1143. (Pubitemid 32472514)
139. Kim, R.B., Leake, B.F., Choo, E.F., Dresser, G.K., Kubba, S.V., Schwarz, U.I. et al. (2001) Identifi cation of functionally variant MDR1 alleles among European Americans and African Americans. Clin. Pharmacol. Ther. , 70, 189-199. (Pubitemid 32777772)
140. Sakaeda, T., Nakamura, T., Horinouchi, M., Kakumoto, M., Ohmoto, N., Sakai, T. et al. (2001) MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects. Pharm. Res. , 18, 1400-1404. (Pubitemid 32977244)
141. Fellay, J., Marzolini, C., Meaden, E.R., Back, D.J., Buclin, T., Chave, J.P. et al. (2002) Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: A pharmacogenetics study. Lancet , 359, 30-36. (Pubitemid 34119193)
142. von, A.N., Richter, M., Grupp, C., Ringe, B., Oellerich, M., and Armstrong, V.W. (2001) No infl uence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-Adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients. Clin. Chem. , 47, 1048-1052. (Pubitemid 32493590)
143. Tang, K., Ngoi, S.M., Gwee, P.C., Chua, J.M., Lee, E.J., Chong, S.S. et al. (2002) Distinct haplotype profi les and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics , 12, 437-450. (Pubitemid 34913526)
144. Machado, J.C., Pharoah, P., Sousa, S., Carvalho, R., Oliveira, C.,
145. Sicinschi, L.A., Lopez-Carrillo, L., Camargo, M.C., Correa, P., Sierra, R.A., Henry, R.R. et al. (2006) Gastric cancer risk in a Mexican population: Role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and -10 genes. Int. J. Cancer , 118, 649-657. (Pubitemid 43076014)
146. Xue, H., Lin, B., Ni, P., Xu, H., and Huang, G. (2010) Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: A meta-Analysis. J Gastroenterol. Hepatol. , 25, 1604-1617.
147. Wang, P., Xia, H.H., Zhang, J.Y., Dai, L.P., Xu, X.Q., and Wang, K.J. (2007) Association of interleukin-1 gene polymorphisms with gastric cancer: A meta-Analysis. Int. J Cancer , 120, 552-562. (Pubitemid 44969026)
148. Camargo, M.C., Mera, R., Correa, P., Peek, R.M., Jr., Fontham, E.T., Goodman, K.J. et al. (2006) Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: A meta-Analysis. Cancer Epidemiol. Biomarkers Prev. , 15, 1674-1687. (Pubitemid 44497104)
149. Persson, C., Canedo, P., Machado, J.C., El-Omar, E.M., and Forman, D. (2011) Polymorphisms in infl ammatory response genes and their association with gastric cancer: A HuGE systematic review and metaanalyses. Am. J Epidemiol. , 173, 259-270.
150. Beales, I.L. and Calam, J. (1998) Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut , 42, 227-234. (Pubitemid 28212178)
151. Chen, H., Wilkins, L.M., Aziz, N., Cannings, C., Wyllie, D.H., Bingle, C. et al. (2006) Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum. Mol. Genet. , 15, 519-529. (Pubitemid 43205418)
152. Arend, W.P., Malyak, M., Guthridge, C.J., and Gabay, C. (1998) Interleukin-1 receptor antagonist: Role in biology. Annu. Rev. Immunol. , 16, 27-55. (Pubitemid 28183358)
153. Andus, T., Daig, R., Vogl, D., Aschenbrenner, E., Lock, G., Hollerbach, S. et al. (1997) Imbalance of the interleukin 1 system in colonic mucosa-Association with intestinal infl ammation and interleukin 1 receptor antagonist (corrected) genotype 2. Gut , 41, 651-657. (Pubitemid 27496145)
154. Tountas, N.A., Casini-Raggi, V., Yang, H., Di Giovine, F.S., Vecchi, M., Kam, L. et al. (1999) Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology , 117, 806-813. (Pubitemid 29468222)
155. Shih, C.M., Lee, Y.L., Chiou, H.L., Chen, W., Chang, G.C., Chou, M.C. et al. (2006) Association of TNF-Alpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer , 52, 15-20. (Pubitemid 43340194)
156. Zambon, C.F., Basso, D., Navaglia, F., Belluco, C., Falda, A., Fogar, P. et al. (2005) Pro- and anti-infl ammatory cytokines gene polymorphisms and Helicobacter pylori infection: Interactions infl uence outcome. Cytokine , 29, 141-152. (Pubitemid 40126232)
157. Hellmig, S., Fischbach, W., Goebeler-Kolve, M.E., Folsch, U.R., Hampe, J., and Schreiber, S. (2005) A functional promotor polymorphism of TNF-Alpha is associated with primary gastric B-Cell lymphoma. Am. J. Gastroenterol. , 100, 2644-2649. (Pubitemid 43922149)
158. Kido, S., Kitadai, Y., Hattori, N., Haruma, K., Kido, T., Ohta, M. et al. (2001) Interleukin 8 and vascular endothelial growth factor-prognostic factors in human gastric carcinomas? Eur. J. Cancer , 37, 1482-1487. (Pubitemid 32744677)
159. Kitadai, Y., Haruma, K., Mukaida, N., Ohmoto, Y., Matsutani, N., Yasui, W. et al. (2000) Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8. Clin. Cancer Res. , 6, 2735-2740. (Pubitemid 30482112)
160. Savage, S.A., Abnet, C.C., Mark, S.D., Qiao, Y.L., Dong, Z.W., Dawsey, S.M. et al. (2004) Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. , 13, 2251-2257. (Pubitemid 40054325)
161. Kato, I., Van Doorn, L.J., Canzian, F., Plummer, M., Franceschi, S., Vivas, J. et al. (2006) Host-bacterial interaction in the development of gastric precancerous lesions in a high risk population for gastric cancer in Venezuela. Int. J. Cancer , 119, 1666-1671. (Pubitemid 44258774)
162. Mege, J.L., Meghari, S., Honstettre, A., Capo, C., and Raoult, D. (2006) The two faces of interleukin 10 in human infectious diseases. Lancet Infect. Dis. , 6, 557-569. (Pubitemid 44262343)
163. Havranek, E., Howell, W.M., Fussell, H.M., Whelan, J.A., Whelan, M.A., and Pandha, H.S. (2005) An interleukin-10 promoter polymorphism may infl uence tumor development in renal cell carcinoma. J. Urol. , 173, 709-712. (Pubitemid 40239324)
164. Nikolova, P.N., Pawelec, G.P., Mihailova, S.M., Ivanova, M.I., Myhailova, A.P., Baltadjieva, D.N. et al. (2007) Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population. Cancer Immunol. Immunother. , 56, 371-379. (Pubitemid 46035905)
165. Seifart, C., Plagens, A., Dempfl e, A., Clostermann, U., Vogelmeier, C., von, W.P. et al. (2005) TNF-Alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer. Dis. Markers , 21, 157-165. (Pubitemid 41566735)
166. Sakamoto, H., Yoshimura, K., Saeki, N., Katai, H., Shimoda, T., Matsuno, Y. et al. (2008) Genetic variation in PSCA is associated with susceptibility to diffuse-Type gastric cancer. Nat. Genet. , 40, 730-740. (Pubitemid 351748870)
167. Lu, Y., Chen, J., Ding, Y., Jin, G., Wu, J., Huang, H. et al. (2010) Genetic variation of PSCA gene is associated with the risk of both diffuse- and intestinal-Type gastric cancer in a Chinese population. Int. J Cancer , 127, 2183-2189.
168. Abnet, C.C., Freedman, N.D., Hu, N., Wang, Z., Yu, K., Shu, X.O. et al. (2010) A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat. Genet. , 42, 764-767.
169. Bird, A. (2002) DNA methylation patterns and epigenetic memory. Genes. Dev. , 16, 6-21. (Pubitemid 34049633)
170. Wang, Y. and Leung, F.C. (2004) An evaluation of new criteria for CpG islands in the human genome as gene markers. Bioinformatics. , 20, 1170-1177. (Pubitemid 38660354)
171. Tate, P.H. and Bird, A.P. (1993) Effects of DNA methylation on DNA-binding proteins and gene expression. Curr. Opin. Genet. Dev. , 3, 226-231. (Pubitemid 23108662)
172. Nan, X., Meehan, R.R., and Bird, A. (1993) Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res. , 21, 4886-4892. (Pubitemid 23330162)
173. Prendergast, G.C. and Ziff, E.B. (1991) Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science , 251, 186-189. (Pubitemid 21916865)
174. Watt, F. and Molloy, P.L. (1988) Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes. Dev. , 2, 1136-1143.
175. Jones, P.L., Veenstra, G.J., Wade, P.A., Vermaak, D., Kass, S.U., Landsberger, N. et al. (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. , 19, 187-191. (Pubitemid 28248804)
176. Nan, X., Ng, H.H., Johnson, C.A., Laherty, C.D., Turner, B.M., Eisenman, R.N. et al. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature , 393, 386-389. (Pubitemid 28269714)
177. Kim, G.D., Ni, J., Kelesoglu, N., Roberts, R.J., and Pradhan, S. (2002) Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J , 21, 4183-4195. (Pubitemid 34857450)
178. Okano, M., Bell, D.W., Haber, D.A., and Li, E. (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell , 99, 247-257. (Pubitemid 29519904)
179. Fan, H., Liu, D., Qiu, X., Qiao, F., Wu, Q., Su, X. et al. (2010) A functional polymorphism in the DNA methyltransferase-3A promoter modifi es the susceptibility in gastric cancer but not in esophageal carcinoma. BMC. Med. , 8, 12.
180. Esteller, M. (2002) CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future. Oncogene , 21, 5427-5440. (Pubitemid 34983479)
181. Yamashita, S., Tsujino, Y., Moriguchi, K., Tatematsu, M., and Ushijima, T. (2006) Chemical genomic screening for methylationsilenced genes in gastric cancer cell lines using 5-Aza-2 ¢ -deoxycytidine treatment and oligonucleotide microarray. Cancer Sci. , 97, 64-71. (Pubitemid 43257029)
182. Schneider, B.G., Peng, D.F., Camargo, M.C., Piazuelo, M.B., Sicinschi, L.A., Mera, R. et al. (2010) Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer. Int. J Cancer , 127, 2588-2597.
183. Shen, H., Xu, Y., Zheng, Y., Qian, Y., Yu, R., Qin, Y. et al. (2001) Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: A case-control study. Int. J Cancer , 95, 332-336. (Pubitemid 32847046)
184. Neves Filho, E.H., Alves, M.K., Lima, V.P., and Rabenhorst, S.H. (2010) MTHFR C677T polymorphism and differential methylation status in gastric cancer: An association with Helicobacter pylori infection. Virchows Arch. , 457, 627-633.
185. Dong, C.X., Deng, D.J., Pan, K.F., Zhang, L., Zhang, Y., Zhou, J. et al. (2009) Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: A population-based study. Int. J Cancer , 124, 434-439.
186. Kague, E., Thomazini, C.M., Pardini, M.I., de, C.F., Leite, C.V., and Pinheiro, N.A. (2010) Methylation status of CDH1 gene in samples of gastric mucous from Brazilian patients with chronic gastritis infected by Helicobacter pylori. Arq Gastroenterol. , 47, 7-12.
187. Alves, M.K., Lima, V.P., Ferrasi, A.C., Rodrigues, M.A., De Moura Campos Pardini MI, and Rabenhorst, S.H. (2010) CDKN2A promoter methylation is related to the tumor location and histological subtype and associated with Helicobacter pylori fl aA(+) strains in gastric adenocarcinomas. APMIS , 118, 297-307.
188. Chan, A.O., Peng, J.Z., Lam, S.K., Lai, K.C., Yuen, M.F., Cheung, H.K. et al. (2006) Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut , 55, 463-468.
189. Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P. et al. (1998) E-cadherin germline mutations in familial gastric cancer. Nature , 392, 402-405. (Pubitemid 28168738)
190. Yoo, E.J., Park, S.Y., Cho, N.Y., Kim, N., Lee, H.S., Kim, D. et al. (2010) Infl uence of IL1B polymorphism on CpG island hypermethylation in Helicobacter pylori-infected gastric cancer. Virchows Arch. , 456, 647-652.
191. McMichael, A.J., McCall, M.G., Hartshorne, J.M., and Woodings, T.L. (1980) Patterns of gastro-intestinal cancer in European migrants to Australia: The role of dietary change. Int. J Cancer , 25, 431-437. (Pubitemid 10153403)
192. Haenszel, W. and Kurihara, M. (1968) Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl. Cancer Inst. , 40, 43-68.
193. Plummer, M., Franceschi, S., and Munoz, N. (2004) Epidemiology of gastric cancer. IARC Sci. Publ. ,311-326.
194. Lunet, N., Valbuena, C., Vieira, A.L., Lopes, C., Lopes, C., David, L. et al. (2007) Fruit and vegetable consumption and gastric cancer by location and histological type: Case-control and meta-Analysis. Eur. J Cancer Prev. , 16, 312-327. (Pubitemid 47165297)
195. Terry, P., Nyren, O., and Yuen, J. (1998) Protective effect of fruits and vegetables on stomach cancer in a cohort of Swedish twins. Int. J Cancer , 76, 35-37. (Pubitemid 28164566)
196. Jansen, M.C., Bueno-de-Mesquita, H.B., Rasanen, L., Fidanza, F., Menotti, A., Nissinen, A. et al. (1999) Consumption of plant foods and stomach cancer mortality in the seven countries study. Is grain consumption a risk factor? Seven Countries Study Research Group. Nutr. Cancer , 34, 49-55. (Pubitemid 29382915)
197. Risch, H.A., Jain, M., Choi, N.W., Fodor, J.G., Pfeiffer, C.J., Howe, G.R. et al. (1985) Dietary factors and the incidence of cancer of the stomach. Am. J Epidemiol. , 122, 947-959. (Pubitemid 16170031)
198. Nomura, A.M., Hankin, J.H., Kolonel, L.N., Wilkens, L.R., Goodman, M.T., and Stemmermann, G.N. (2003) Case-control study of diet and other risk factors for gastric cancer in Hawaii (United States). Cancer Causes Control , 14, 547-558. (Pubitemid 37006433)
199. Lagiou, P., Samoli, E., Lagiou, A., Peterson, J., Tzonou, A., Dwyer, J. et al. (2004) Flavonoids, vitamin C and adenocarcinoma of the stomach. Cancer Causes Control , 15, 67-72. (Pubitemid 38339973)
200. Ramon, J.M., Serra-Majem, L., Cerdo, C., and Oromi, J. (1993) Nutrient intake and gastric cancer risk: A case-control study in Spain. Int. J Epidemiol. , 22, 983-988. (Pubitemid 24025674)
201. Kaaks, R., Tuyns, A.J., Haelterman, M., and Riboli, E. (1998) Nutrient intake patterns and gastric cancer risk: A case-control study in Belgium. Int. J Cancer , 78, 415-420. (Pubitemid 28481157)
202. Palli, D., Russo, A., and Decarli, A. (2001) Dietary patterns, nutrient intake and gastric cancer in a high-risk area of Italy. Cancer Causes Control , 12, 163-172. (Pubitemid 32165274)
203. Mayne, S.T., Risch, H.A., Dubrow, R., Chow, W.H., Gammon, M.D., Vaughan, T.L. et al. (2001) Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol. Biomarkers Prev. , 10, 1055-1062. (Pubitemid 32959152)
204. De, S.E., Correa, P., Boffetta, P., eo-Pellegrini, H., Ronco, A.L., and Mendilaharsu, M. (2004) Dietary patterns and risk of gastric cancer: A case-control study in Uruguay. Gastric. Cancer , 7, 211-220.
205. Campos, F., Carrasquilla, G., Koriyama, C., Serra, M., Carrascal, E., Itoh, T. et al. (2006) Risk factors of gastric cancer specific for tumor location and histology in Cali, Colombia. World J Gastroenterol. , 12, 5772-5779. (Pubitemid 44594243)
206. Wirth, H.P., Beins, M.H., Yang, M., Tham, K.T., and Blaser, M.J. (1998) Experimental infection of Mongolian gerbils with wild-Type and mutant Helicobacter pylori strains. Infect. Immun. , 66, 4856-4866. (Pubitemid 28453093)
207. Dey, A., Yokota, K., Kobayashi, K., Oguma, K., Hirai, Y., and Akagi, T. (1998) Antibody and cytokine responses in Helicobacter pyloriinfected various mouse strains. Acta Med. Okayama , 52, 41-48. (Pubitemid 128456885)
208. Marchetti, M., Arico, B., Burroni, D., Figura, N., Rappuoli, R., and Ghiara, P. (1995) Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science , 267, 1655-1658.
209. D'Elios, M.M., Manghetti, M., Almerigogna, F., Amedei, A., Costa, F., Burroni, D. et al. (1997) Different cytokine profile and antigenspecifi city repertoire in Helicobacter pylorispecific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur. J. Immunol. , 27, 1751-1755. (Pubitemid 27302859)
210. D'Elios, M.M., Manghetti, M., De, C.M., Costa, F., Baldari, C.T., Burroni, D. et al. (1997) T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. , 158, 962-967. (Pubitemid 127492677)
211. Sommer, F., Faller, G., Konturek, P., Kirchner, T., Hahn, E.G., Zeus, J. et al. (1998) Antrumand corpus mucosa-infi ltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect. Immun. , 66, 5543-5546. (Pubitemid 29044657)
212. Maeda, S., Yoshida, H., Ogura, K., Mitsuno, Y., Hirata, Y., Yamaji, Y. et al. (2000) H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. Gastroenterology , 119, 97-108. (Pubitemid 30452583)
213. Yasumoto, K., Okamoto, S., Mukaida, N., Murakami, S., Mai, M., and Matsushima, K. (1992) Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene. J. Biol. Chem. , 267, 22506-22511.
214. Mitsuno, Y., Yoshida, H., Maeda, S., Ogura, K., Hirata, Y., Kawabe, T. et al. (2001) Helicobacter pylori induced transactivation of SRE and AP-1 through the ERK signalling pathway in gastric cancer cells. Gut , 49, 18-22. (Pubitemid 32601874)
215. Karttunen, R.A., Karttunen, T.J., Yousfi , M.M., el-Zimaity, H.M., Graham, D.Y., and el-Zaatari, F.A. (1997) Expression of mRNA for interferon-gamma, interleukin-10, and interleukin-12 (p40) in normal gastric mucosa and in mucosa infected with Helicobacter pylori. Scand. J. Gastroenterol. , 32, 22-27. (Pubitemid 27026462)
216. Ye, G., Barrera, C., Fan, X., Gourley, W.K., Crowe, S.E., Ernst, P.B. et al. (1997) Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells: Potential role in CD4+ T cell activation during Helicobacter pylori infection. J. Clin. Invest , 99, 1628-1636. (Pubitemid 27163813)
217. Allen, L.A., Schlesinger, L.S., and Kang, B. (2000) Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. J. Exp. Med. , 191, 115-128.
218. Kuwahara, H., Miyamoto, Y., Akaike, T., Kubota, T., Sawa, T., Okamoto, S. et al. (2000) Helicobacter pylori urease suppresses bactericidal activity of peroxynitrite via carbon dioxide production. Infect. Immun. , 68, 4378-4383. (Pubitemid 30497701)